Nurse Practitioner, Family · Miami, FL
NPI
1154996056
Since 2021
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
1400 NW 12th Ave
Miami, FL, 33136
Phone (305) 243-8644
Groups this clinician bills Medicare through
Medicare paid, 2024
$12K
173 services
Medicare patients, 2024
98
Average age 68
Drug cost, 2024
$5.9M
812 prescriptions
Company payments, 2025
$38.17
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Mailenys Ortega was code 99214 (office e&m - established), 92 times for 59 patients. In total Mailenys Ortega billed 173 services in 7 codes, and Medicare paid $12K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-08-12.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 92 | 59 | $61.56 | $5,664 |
| 99214 Office E&M - Established | Office | 66 | 49 | $84.68 | $5,589 |
By year: 2022 $7,117 for 125 services; 2023 $11K for 164 services; 2024 $12K for 173 services.
Medicare prescription drug claims, 2024
In 2024, the drug Mailenys Ortega prescribed most often to Medicare patients was Stelara (Ustekinumab), with 122 prescriptions and refills. In total Mailenys Ortega wrote 812 Medicare prescriptions that cost $5.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Stelara Ustekinumab | 122 | 156 | 19 | $3.2M |
| Humira(Cf) Pen Adalimumab | 70 | 71 | Under 11 | $943K |
| Pantoprazole Sodium Generic | 69 | 118 | 20 | $442 |
| Skyrizi On-Body Risankizumab-Rzaa | 58 | 97 | 15 | $1.2M |
| Mesalamine Generic | 49 | 115 | 20 | $26K |
| Famotidine Generic | 47 | 89 | 17 | $665 |
| Rinvoq Upadacitinib | 29 | 29 | Under 11 | $241K |
| Omeprazole Generic | 28 | 55 | Under 11 | $228 |
| Sulfasalazine Generic | 25 | 27 | Under 11 | $442 |
| Ondansetron Odt Ondansetron | 23 | 23 | Under 11 | $205 |
| Loperamide Loperamide Hcl | 20 | 26 | Under 11 | $589 |
| Dicyclomine Hcl Generic | 16 | 18 | Under 11 | $486 |
| Prednisone Generic | 15 | 20 | Under 11 | $83.49 |
| Ondansetron Hcl Generic | 14 | 14 | Under 11 | $260 |
| Sucralfate Generic | 14 | 14 | Under 11 | $361 |
Brand drugs: - claims; generic drugs: 435 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Mailenys Ortega $38.17 ($38.17 in general payments such as food, travel and fees) from 2 companies. The largest payer was Bayer Healthcare Pharmaceuticals Inc. with $22.56.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.